Ovarian ablation in early breast cancer: overview of the randomised trials

Ovarian ablation in early breast cancer: overview of the randomised trials

<p><strong>Background</strong> Among women with early breast cancer, the effects of ovarian ablation on recurrence and death have been assessed by several randomised trials that now have long follow-up. In this report, the Early Breast Cancer Trialists' Collaborative Group pre...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteur:	Early Breast Cancer Trialists' Collaborative Group
Andere auteurs:	Clarke, M
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	Elsevier 1996

Gelijkaardige items

Polychemotherapy for early breast cancer: an overview of the randomised trials
door: Early Breast Cancer Trialists' Collaborative Group
Gepubliceerd in: (1998)

Tamoxifen for early breast cancer: an overview of the randomised trials
door: Early Breast Cancer Trialists' Collaborative Group
Gepubliceerd in: (1998)

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
door: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Gepubliceerd in: (2005)

Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials
door: Early Breast Cancer Trialists' Collaborative Group
Gepubliceerd in: (1995)

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
door: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Gepubliceerd in: (2005)

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
door: Early Breast Cancer Trialists’ Collaborative Group
Gepubliceerd in: (2017)

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: patient level meta-analysis of 7,030 women in four randomised trials
door: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Gepubliceerd in: (2022)

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials
door: Early Breast Cancer Trialists’ Collaborative group (EBCTCG)
Gepubliceerd in: (2021)

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast
door: Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
Gepubliceerd in: (2010)

Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials
door: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Gepubliceerd in: (2008)

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
door: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Gepubliceerd in: (2011)

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
door: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Gepubliceerd in: (2011)

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer
door: Early Breast Cancer Trialists' Collaborative Group
Gepubliceerd in: (1988)

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials
door: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Gepubliceerd in: (2011)

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
door: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Gepubliceerd in: (2014)

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women
door: Early Breast Cancer Trialist's Collaborative Group
Gepubliceerd in: (1992)

Expert consensus on clinical applications of ovarian function suppression for Chinese women with early breast cancer (2024 edition)
door: Committee of Breast Cancer Society, China Anti-Cancer Association
Gepubliceerd in: (2024-03-01)

Expert consensus on clinical applications of ovarian function suppression for Chinese women with early breast cancer 2021 CACA-CBCS
door: Chinese Anti-Cancer Association, Committee of Breast Cancer Society
Gepubliceerd in: (2022-02-01)

Overview of the Randomised Trials of Radiotherapy in Early Breast Cancer.
door: Darby, S, et al.
Gepubliceerd in: (2009)

Chinese expert consensus recommendations for management of bone health in female patients with early breast cancer (2022 edition)
door: The Society of Breast Cancer of China Anti-Cancer Association, Breast Cancer Study Group Along Yangtze River
Gepubliceerd in: (2022-03-01)

WITHDRAWN: Ovarian ablation for early breast cancer.
door: Clarke, M
Gepubliceerd in: (2008)

20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years
door: Pan, H, et al.
Gepubliceerd in: (2017)

Screening and early diagnosis of breast cancer in China: a practice guideline
door: The Society of Breast Cancer, China Anti-Cancer Association
Gepubliceerd in: (2022-04-01)

Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies.
door: Collaborative Group on Epidemiological Studies of Ovarian Cancer
Gepubliceerd in: (2012-01-01)

Systematic review of purine analog treatment for chronic lymphocytic leukemia: lessons for future trials.
door: CLL Trialists’ Collaborative Group
Gepubliceerd in: (2012)

Guidelines for breast cancer diagnosis and treatment by China Anti-cancer Association (2024 edition)
door: The Society of Breast Cancer China Anti-Cancer Association, Breast Oncology Group of the Oncology Branch of the Chinese Medical Association
Gepubliceerd in: (2023-12-01)

Systematic review of purine analog treatment for chronic lymphocytic leukemia: lessons for future trials
door: CLL Trialists’ Collaborative Group (CLLTCG)
Gepubliceerd in: (2012-03-01)

Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials.
door: Stem Cell Trialists' Collaborative Group
Gepubliceerd in: (2005)

Details of a prospective protocol for a collaborative meta-analysis of individual participant data from all randomized trials of intravenous rt-PA vs. control: statistical analysis plan for the Stroke Thrombolysis Trialists' Collaborative meta-analysis.
door: Stroke Thrombolysis Trialists' Collaborative Group
Gepubliceerd in: (2013)

Expert consensus on neoadjuvant treatment of breast cancer in China (2021 edition)
door: Expert group of expert consensus on neoadjuvant treatment of breast cancer in China ( edition)
Gepubliceerd in: (2022-01-01)

The benefits and harms of breast cancer screening: an independent review.
door: Independent UK Panel on Breast Cancer Screening
Gepubliceerd in: (2012)

Expert consensus on oncoplastic surgery of breast tumor and breast reconstruction (2022 edition)
door: Committee of Breast Cancer Society, Chinese Anti-Cancer Association, Breast Surgeons Committee of Surgeons Branch, Chinese Medical Doctor Association, Committee of Breast Cancer Society, Shanghai Anti-Cancer Association
Gepubliceerd in: (2022-09-01)

Treatment of early-stage breast cancer with percutaneous thermal ablation, an open-label randomised phase 2 screening trial: rationale and design of the THERMAC trial
door: Erwin Birnie, et al.
Gepubliceerd in: (2021-09-01)

Birth size and breast cancer risk: re-analysis of individual participant data from 32 studies.
door: Isabel dos Santos Silva, et al.
Gepubliceerd in: (2008-09-01)

The role of hormonal ovarian ablation in adjuvant treatment of premenopausal breast cancer
door: Murtezani Zafir, et al.
Gepubliceerd in: (2011-01-01)

Caesarean section surgical techniques: a randomised factorial trial (CAESAR).
door: CAESAR study collaborative group
Gepubliceerd in: (2010)

Ovarian Function, Not Age, Predicts the Benefit from Ovarian Suppression or Ablation for Premenopausal Women with Breast Cancer.
door: Cong Xue, et al.
Gepubliceerd in: (2016-01-01)

Early breast cancer - the randomised evidence
door: Peto, R, et al.
Gepubliceerd in: (1999)

NOTIFICATION: Development of a Novel Approach for Breast Cancer Prediction and Early Detection Using Minimally Invasive Procedures and Molecular Analysis: How Cytomorphology Became a Breast Cancer Risk Predictor
door: The Breast Journal
Gepubliceerd in: (2025-01-01)

Chinese consensus of cardio-oncology in breast cancer
door: SHEN Zan, SHAO Zhimin, Cancer Support Rehabilitation Therapy Group of Chinese Medical Association Oncology Branch, the Drafting Committee of China Breast Cancer Related Heart Disease Diagnosis and Treatment Consensus
Gepubliceerd in: (2022-10-01)